Pixantrone Overview in Non-Hodgkin's Lymphoma to be Presented at 2009 Pan Pacific Lymphoma Conference
SEATTLE, June 16 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today announced that Richard Van der Jagt, M.D. of Ottawa Hospital will be presenting an overview of pixantrone clinical studies in non-Hodgkin's lymphoma at the 2009 Pan Pacific Lymphoma Conference on Monday, June 22, 2009. The conference will be held from June 22-26, 2009 at the Fairmont Orchid hotel on the Big Island of Hawaii.
2009 Pan Pacific Lymphoma Conference
Pixantrone Presentation: Monday, June 22, 2009
June 22-26, 2009
The Fairmont Orchid
1 North Kaniku Drive
Kohala Coast, Big Island, Hawaii 96743
Media Contact:
Dan Eramian
T: 206.272.4343
C: 206.854.1200
E: deramian@ctiseattle.com
www.CellTherapeutics.com/press_room
Investors Contact:
Ed Bell
T: 206.282.7100
Lindsey Jesch Logan
T: 206.272.4347
F: 206.272.4434
E: invest@ctiseattle.com
www.CellTherapeutics.com/investors
Source: Cell Therapeutics, Inc.
CONTACT: Dan Eramian, +1-206-272-4343, Cell, +1-206-854-1200, deramian@ctiseattle.com, or Investors, Ed Bell, +1-206-282-7100, or Lindsey Jesch Logan, +1-206-272-4347, or fax, +1-206-272-4434, invest@ctiseattle.com, all of Cell Therapeutics, Inc.
Web Site: http://www.celltherapeutics.com
Posted: June 2009
